Document is current
Any future updates will be listed below
-
Authors
Kuemmel, Sherko https://orcid.org/0000-0001-9355-494X
Harrach, Hakima
Schmutzler, Rita K.
Kostara, Athina
Ziegler-Löhr, Katja
Dyson, Mark H.
Chiari, Ouafaa
Reinisch, Mattea https://orcid.org/0000-0002-1381-8595
- License Information
-
More Information
Article History
Received: 5 February 2020
Accepted: 23 June 2020
First Online: 24 July 2020
Competing interests
: S.K. reports receiving personal fees from Roche, Genomic Health, Novartis, Amgen, Celgene, Daiichi Sankyo, Astra Zeneca, Somatex, MSD, Pfizer, Puma Biotechnology, PFM Medical and Lilly, and nonfinancial support from Roche, Daiichi Sankyo, Somatex and Sonoscape (outside the submitted work). A.K. reports receiving personal fees from Astra Zeneca and nonfinancial support from Tesaro and MSD (outside the submitted work). M.H.D. reports receiving personal fees from Boehringer Ingelheim, Merck, Novartis, EUSA Pharma, AbbVie, Janssen, Biogen, Menarini, and Norgine (outside the submitted work). M.R. reports receiving personal fees from Novartis, Lilly, Roche, Pfizer, Astra Zeneca, MSD and Somatex, and travel grants from Novartis, Pfizer and Celgene. Other authors report no competing interests.
